H02 logo

Haw Par Corporation
H02

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
SGD3.42B
EV
SGD2.67B
Shares Outstanding
221.37M
Beta
0.21
Industry
Drug Manufacturers - General

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E 2026E
12.75x
P/Revenue 2026E
15.37x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2026E
-
Net Profit Margin 2026E
112.85%
ROE 2026E
5.90%
ROCE 2025
6.29%

Dividends

DPS 2026E
SGD0.45
Payout Ratio 2026E
36.00%
Div. Yield 2026E
2.69%
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Haw Par Corporation Limited

gainify
H02 logo

Haw Par Corporation Limited

H02

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topica...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Wee, Ee Lim

Employees

595

IPO Date

2000-01-03

Headquarters

No. 03-03 Haw Par Technocentre, 401 Commonwealth Drive, Singapore 149598, Singapore

📊 Stock Price & Performance

The last closing price of Haw Par Corporation (H02) is SGD16.77, reflecting a -1.30% change from the prior session. Last updated: April 2, 2026 at 6:19 AM Eastern Time

Review of Recent H02 Stock Performance trends:Past 1 Month: Haw Par Corporation (H02) shares changed by -7.71%.Past 3 Months: The stock recorded a change of -1.09%.Past 6 Months: H02 shares posted a change of +8.12%. Last updated: March 7, 2026 at 8:53 PM Eastern Time

Over the last year, Haw Par Corporation (H02) has established a 52-week price range between a high of SGD17.33 and a low of SGD11.30. This metric is essential for assessing the stock's annual volatility. Last updated: March 7, 2026 at 8:53 PM Eastern Time

Haw Par Corporation (H02) is considered a low volatility stock. It has a beta of 0.21, which means it typically moves 0.21 times as much as the broader market. Over the past 52 weeks, H02 has traded within a SGD11.30 – SGD17.33 range. Last updated: March 7, 2026 at 8:53 PM Eastern Time

A SGD1,000 investment in Haw Par Corporation 5 years ago, when the stock was trading around SGD13.52, would be worth approximately SGD1240.23 today, based solely on share price performance (excluding dividends). This represents a total return of 24.02% over the period, equivalent to a compound annual growth rate (CAGR) of 4.40%. Past performance reflects historical price movements only and does not imply future results. Last updated: March 7, 2026 at 8:53 PM Eastern Time

💰 Financial Metrics & Reports

The current Haw Par Corporation (H02) market capitalization is approximately SGD3.42B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Haw Par Corporation's market cap fluctuates with changes in its share price and share count. Last updated: March 7, 2026 at 8:53 PM Eastern Time

In the most recently reported quarter, Haw Par Corporation (H02) generated SGD51.81M in revenue, representing a -18.22% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: April 2, 2026 at 4:08 AM Eastern Time

In the most recently reported fiscal year, Haw Par Corporation (H02) generated net income of SGD265.46M, compared with SGD228.27M in the prior fiscal year, representing a +16.29% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of SGD276.12M. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: April 2, 2026 at 4:08 AM Eastern Time

According to its latest quarterly filing, Haw Par Corporation (H02) reported EBITDA of SGD18.51M, representing a +4.54% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: April 2, 2026 at 4:08 AM Eastern Time

As of the most recent reporting period, the company's debt-to-equity ratio stands at 0.01x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: April 2, 2026 at 4:08 AM Eastern Time

Based on the latest available data, Haw Par Corporation (H02) is currently trading at a last twelve months (LTM) P/E ratio of 13.99x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: April 2, 2026 at 6:19 AM Eastern Time

📅 Earnings & Dividends

In the most recently reported quarter, Haw Par Corporation (H02) revenue was SGD51.81M. Earnings per share (EPS) for the quarter were SGD0.27. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: April 2, 2026 at 4:08 AM Eastern Time

📈 Analyst Information

Based on the latest available analyst coverage, Haw Par Corporation (H02) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: April 2, 2026 at 6:19 AM Eastern Time

Like other publicly traded stocks, Haw Par Corporation (H02) shares are bought and sold on stock exchanges such as SGX and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Haw Par Corporation (H02) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add H02 to your watchlist.

Haw Par Corporation trades under the ticker symbol H02 on the SGX stock exchange. The ticker H02 is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

As of the most recently reported period, Haw Par Corporation (H02) employs approximately 595 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: March 7, 2026 at 8:53 PM Eastern Time

Haw Par Corporation (H02) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Haw Par Corporation (H02) stock peers based on overlapping products, services, and competitive dynamics:AFT Pharmaceuticals (AFT)Hyphens Pharma International (1J5)Whan In Pharm (A016580)Nxera Pharma (4565)Shanghai Kaibao Pharmaceutical (300039)GlaxoSmithKline Pakistan (GLAXO)Theragen Etex (A066700)JW Lifescience (A234080)Lee's Pharmaceutical Holdings (950)Egyptian International Pharmaceutical Industries (PHAR) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Haw Par Corporation.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.